Japan establishes new drug development hub to boost innovation
The decision reflects Japan’s growing concern over its lag in approving new therapies compared to the U.S. and Europe.
Stay updated with the latest news and articles about Medicines.
The decision reflects Japan’s growing concern over its lag in approving new therapies compared to the U.S. and Europe.
The president set a two-week deadline for his ministers to present actionable solutions.
Prime Minister Fumio Kishida announced that the government is committed to expediting the development of essential medicines, with an operational start date set for April 2026. The roadmap outlines the establishment of over ten pharmaceutical startups by 2028, supported by a doubling of investment in drug development.
Pakistan's surging drug prices raise concerns about affordability. A new MoU with China's market regulator promises information and technical expertise sharing.